Amanta Healthcare, a pharmaceutical manufacturing company from the state of Gujarat has set the price band of its Initial Public Offering between ₹120 and ₹126 per share. The company is willing to collect ₹126 crores to finance new factory projects and improve their product line.
Amanta Healthcare Ltd. is a company from Desa Hariyala, District Kheda, Gujarat, that offers pharmaceutical products. The company commenced operations in 1994 with a healthcare division which included sterile liquid formulations and medical devices. One of their products is IV fluids, diluents, ophthalmic solutions, respiratory care products, irrigation solutions and eye lubricating products. The latest technology such as Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) is used in packaging. Amanta Healthcare has become an international exporter from a local player by establishing its footprint in Africa, Latin America, and the UK.
IPO Structure and Price Band
The company has disclosed its Initial Public Offering (IPO) with a price range from 120 to 126 Rs per share of equity. By issuing 1 crore fresh shares to the public, Amanta Healthcare plans to collect ₹126 crores. Notably, the current issue consists entirely of a fresh issue of shares, so there will not be any selling of shares by the promoters.
As per the Red Herring Prospectus (RHP), the issue structure allocates:
- 50% to Qualified Institutional Buyers (QIBs),
- 35% to Retail Individual Investors (RIIs), and
- 15% to Non-Institutional Investors (NIIs).
IPO Timeline and Allotment Details
The subscription window will be available on Monday, September 1, 2025, and it will be closed on Wednesday, September 3, 2025. The anchor investor allocation is expected to take place on Friday, August 29, 2025.
Basis for allotment: Thursday, September 4, 2025
Expected listing: Monday, September 9, 2025
The size of the lot has been determined at 119 shares, thus retail investors are required to make a minimum investment of ₹14,994. The maximum bid allowed for retail investors is limited to 13 lots.Use of Proceeds
Funds raised will be channelled towards:
- Civil construction work for expansion at its Hariyala facility in Gujarat,
- Purchase of plant and machinery to set up new manufacturing lines for SteriPort and SVP products,
- General corporate purposes.
Issue Management
The IPO is being managed by Beeline Capital Advisors as the Book Running Lead Manager (BRLM), while MUFG Intime India Pvt Ltd serves as the Registrar of the Issue.
Company’s Growth Potential
Amanta Healthcare has been dealing with the management of fluid therapy and sterile solutions, successfully, for over two decades. The company has been establishing its position in the market without any break. Their dedication to innovation and global quality standards can be seen in their modern production lines and research and development labs.
The IPO that the company will be making in the near future is probably going to be the reason for a subsequent rise in the local and foreign market demands, hence, a deeper penetration of the Indian pharma industry, which is already witnessing a rapid expansion of the pharmaceutical sector.
READ MORE ON
